Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: ROCKLEY receives negative research report

https://thefly.com/landingPageNews.php?id=3498309&headline=RKLY;AAPL-Rockley-Photonics-falls-after-Iceberg-Research-reveals-short-position

 

 

RKLY, AAPL 10:10 04/22/22 Rockley Photonics falls after Iceberg Research reveals short position Iceberg Research said via Twitter: "We are short Rockley Photonics $RKLY. We believe the company is experiencing technological roadblocks and will soon face a cash crunch and heavy dilution. Rockley is a UK-based startup that is developing biosensors for integration with smartwatches and medical devices. The company claims its spectrography tech has 1,000,000x higher resolution and is 1,000x more accurate than the LED tech already used in smartwatches. It would also detect a wider selection of biomarkers than LED: ethanol, lactate, glucose, etc. Confident in its technology, Rockley plans commercialisation of its standalone biosensor solution in 2022 and integration into smartwatches in 2023. Meanwhile, Bloomberg recently reported that Apple delayed a blood pressure function in its smartwatch till at least 2024. Its sources, who asked not to be identified as 'the matter is private', said 'accuracy has been a challenge during testing'...We strongly believe the technology Apple struggles with is Rockley's." Reference Link RKLY AAPL

Read more at:
https://thefly.com/n.php?id=3498309
Share
New Message
Please login to post a reply